DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Gallagher DJ. et al.
Final results of a phase II study of sunitinib in patients
with relapsed or refractory urothelial cancer.
J Clin Oncol 2008; 26: 5082-
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.